Chemomab Therapeutics (CMMB) Return on Assets [ROA] (2019 - 2026)
Chemomab Therapeutics (CMMB) recorded Return on Assets [ROA] of 68.52% in Q2 2026, down 30.24 percentage points from 98.76% a year earlier but up 10.40 percentage points from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Return on Assets [ROA] (2019 - 2026) Analysis & Trends
For FY2025, Chemomab Therapeutics reported Return on Assets [ROA] of 58.45%, down 12.85 percentage points from FY2024.
- Annual Return on Assets [ROA] has a four-year change of +25.97 percentage points (FY2021 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at 71.30% in FY2024 (-2.98 pp), 74.28% in FY2023 (+20.82 pp), 53.46% in FY2022 (+20.98 pp) and 32.48% in FY2021.
- Quarterly Return on Assets [ROA] has ranged from 2.67% in Q3 2021 to 111.18% in Q3 2023 over the past five years.
- On a year-over-year basis, Return on Assets [ROA] has declined for three consecutive quarters, with an average year-over-year change of -15.70 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 70.57 percentage points in Q2 2023, against a drop of 32.64 percentage points in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 58.12% (Q1 2026), 68.72% (Q4 2025) and 85.84% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Chemomab Therapeutics | 8.56 Mn | 8.56 Mn | - | 68.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 68.52% |
| Mar 31, 2026 | 58.12% |
| Dec 31, 2025 | 68.72% |
| Sep 30, 2025 | 85.84% |
| Jun 30, 2025 | 98.76% |
| Mar 31, 2025 | 89.98% |
| Dec 31, 2024 | 73.66% |
| Sep 30, 2024 | 81.26% |
| Jun 30, 2024 | 92.81% |
| Mar 31, 2024 | 96.50% |
| Dec 31, 2023 | 106.30% |
| Sep 30, 2023 | 111.18% |
| Jun 30, 2023 | 103.18% |
| Mar 31, 2023 | 82.79% |
| Dec 31, 2022 | 39.68% |
| Sep 30, 2022 | 56.61% |
| Jun 30, 2022 | 32.60% |
| Mar 31, 2022 | 14.49% |
| Dec 31, 2021 | 7.55% |
| Sep 30, 2021 | 2.67% |
API Access
Chemomab Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();